肿瘤PET代谢显像剂及其特点

向玲; 张永学

肿瘤PET代谢显像剂及其特点

向玲 , 张永学

文章导航 > 国际放射医学核医学杂志 > 2008, 32 > 3: (133-136)

引用本文:

Citation:

肿瘤PET代谢显像剂及其特点

向玲,
张永学

430022 武汉, 华中科技大学协和医院PET中心, 湖北省分子影像重点实验室

Characteristics of metabolic imaging agents in PET oncology

PET Center, Union Hospital, Huazhong University of Science and Technology, Key Laboratory of Molecular Imaging, Hubei Province, Wuhan 430022, China

摘要: 随着肿瘤PET代谢显像技术的不断发展,其在肿瘤的诊断、治疗及评价等方面的应用也越来越广泛,同时对各种代谢显像剂的研究也日趋深入。综述了各种PET代谢显像剂的基本特性和临床应用,并重点对反映糖代谢、氨基酸代谢和胆碱代谢的显像剂进行评价和比较。
- 肿瘤 /
- 体层摄影术 /
- 发射型计算机 /
- 代谢显像剂
Abstract: As the developing of the PET technology on metabolic imaging,the application in the diagnosis,treatment and evaluation of neoplasms is extending,this also promotes the research on various metabolic imaging agents.This article summarized the characteristics and clinical applications of different kinds of metabolic imaging agents,in which the shcose,amino acid and choline metabolic imaging agents are highlighted.
- Neoplasms /
- Tomography /
- emission-computed /
- Metabolic imaging agents
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Kelloff GJ, Hoffman JM, Johnson B, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development[J]. Clin Cancer Res, 2005, 11(8):2785-2808.
[2]	李家敏,孙启银,赵军,等.¹⁸F-FDG PET显像在肝癌诊断及疗效评价中的应用[J].中华核医学杂志,1998,18(3):181.
[3]	丁勇,张书文,田嘉禾.FDG-PET在肿瘤学中的应用[J].中国医学影像学杂志,2000,8(6):469-471.
[4]	Kumar R, Loving VA, Chauhan A, et al. Potential of dual-timepoint imaging to improve breast cancer diagnosis with ¹⁸F-FDG PET[J]. J Nucl Med, 2005, 46(11):1819-1824.
[5]	张永学,吴志坚,贾清,等. ¹⁸F-FDG PET双时相显像在鉴别良恶性病变中的价值[J].中国医学影像技术,2006,22(9):1415-1417.
[6]	Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point ¹⁸F-FDG PET imaging for the differentiation between malignant and benign lesions[J]. Clin Radiol, 2008, 63(7):756-764.
[7]	Matheja P, Schober O. ¹²³I-IMT SPET:Introducing another research tool into clinical neuro-oncology[J]. Eur J Nucl Med, 2001, 28(1):1-4.
[8]	Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled aminoacids:basic aspects and clinical appacations in oncology[J]. J Nucl Med, 2001, 42(3):432-445.
[9]	Goldman S, Levivier M, Pirotte B, et al. Regional methionine and glucose uptake in high-grade gliomas:a comparative study on PET-guided stereotactic biopsy[J]. J Nucl Med, 1997, 38(9):1459-1462.
[10]	Pieterman R, Willemsen A, Appel M, et al. Visualisation and assessment of the protein synthesis rate of lung cancer using carnbon-11 tyrosine and positron emission tomography[J]. Eur J Nucl Med Mol Imaging, 2002, 29(2):243-247.
[11]	Tang G, Wang M, Tang X, et al. Fully automated synthesis module for preparation of S-(2-[¹⁸F] fluoroethyl)-L-methionlne by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin[J]. Nucl Med Biol, 2003, 30(5):509-512.
[12]	Zhang H, Tian M, Oriuchi N, et al. nC-choline PET for the detection of bone and soft tissue tumors in comparison with FDG PET[J]. Nucl Med Commun, 2003, 24(3):273-279.
[13]	Hara T, Kosaka N, Kondo T, et al. Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with[¹¹C]choline[J]. J Nucl Med, 1997, 38(Suppl):250.
[14]	Vander Borght T, Pauwels S, Lambotte L,et at B rain tumor imaging with PET and 2-[carbon-11] thymidine[J]. J Nucl Med, 1994, 35(6):974-982.
[15]	Been LB, Suurmeijer AJ, Cobben DC, et al. ¹⁸F-FLT-PET in oncology:current status and opportunities[J]. Eur J Nucl Med Mol Imaging, 2004, 31(12):1659-1672.
[16]	Ho CL, Yu SC, Yeung DW. ¹¹C-acetate PET imaging in hepatocellular carcinoma and other liver masses[J]. J Nucl Med, 2003, 44(2):213-221.
[17]	Ho CL, Chen S, Yeung DW, et al. Dual-Tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma[J]. J Nucl Med, 2007, 48(6):902-909.
[18]	霍力,周前,吴战宏,等.¹¹C-乙酸盐PET显像在肾脏肿瘤诊断中的作用[J].中华核医学杂志,2006,26(4):205-208.

[1]	郭宵峰 , 刘建中 , 孙琦婷 . 肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究. 国际放射医学核医学杂志, 2015, 39(4): 277-281. doi: 10.3760/cma.j.issn.1673-4114.2015.04.001
[2]	袁杰 , 刘兴党 , 韩梅 . SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用. 国际放射医学核医学杂志, 2013, 37(1): 30-33, 41. doi: 10.3760/cma.j.issn.1673-4114.2013.01.009
[3]	张高潮 , 马丽 , 寇莹 , 陈正福 , 宋晏 , 徐金亮 . ⁹⁹Tc^m-tetrofosmin SPECT诊断肺部肿瘤的临床价值. 国际放射医学核医学杂志, 2015, 39(4): 303-307. doi: 10.3760/cma.j.issn.1673-4114.2015.04.007
[4]	蔡晓君 , 秦颂兵 , 徐晓婷 , 周菊英 . PET-CT图像融合技术在非小细胞肺癌适形放射治疗中的应用价值. 国际放射医学核医学杂志, 2008, 32(3): 143-146.
[5]	刘阳 , 王会祥 , 周涛 . 神经母细胞瘤股骨远端干骺端骨转移全身骨显像分析. 国际放射医学核医学杂志, 2012, 36(1): 27-29. doi: 10.3760/cma.j.issn.1673-4114.2012.01.007
[6]	苏云龙 , 王雪梅 . ¹²³I-β-甲基-p-碘苯基十五烷酸心肌显像研究进展. 国际放射医学核医学杂志, 2012, 36(1): 16-19, 45. doi: 10.3760/cma.j.issn.1673-4114.2012.01.004
[7]	姚立新 , 刘彬彬 . 门控心肌灌注显像局部室壁运动异常判断冠状动脉狭窄程度的价值. 国际放射医学核医学杂志, 2007, 31(2): 90-93.
[8]	贺小红 , 袁建伟 , 袁白虹 , 梁伟棠 . 提高负荷-再分布²⁰¹Tl心肌显像结果可比性的方法探讨. 国际放射医学核医学杂志, 2010, 34(2): 110-112. doi: 10.3760/cma.j.issn.1673-4114.2010.02.014
[9]	杨宝军 , 李险峰 , 陆克义 , 赵德善 , 李思进 . ⁹⁹Tc^m-二亚乙基三胺五乙酸与⁹⁹Tc^m-奥曲肽眼眶显像在甲状腺相关性眼病中的对比研究. 国际放射医学核医学杂志, 2009, 33(1): 22-25. doi: 10.3760/cma.j.issn.1673-4114.2009.01.022
[10]	孙晓昕 , 田月琴 . PET-CT在冠状动脉疾病的临床应用. 国际放射医学核医学杂志, 2008, 32(3): 150-153.